Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025
1. Quest Diagnostics reported Q3 revenues of $2.82 billion, up 13.1%. 2. Diluted EPS rose 8.5% to $2.16; adjusted EPS up 13% to $2.60. 3. Year-to-date operating cash flow increased 63.1% to $1.4 billion. 4. The company updated full-year 2025 revenue guidance upwards to $10.96 to $11.00 billion. 5. Key partnerships expected to generate $1 billion annual revenue from lab services.